secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apellis Pharmaceuticals, Inc. (APLS)
CIK:        0001492422
Form:       8-K
Filed at:   2022-06-02T23:59:59+00:00
Accession:  0001193125-22-166256
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Apellis shareholders re-elect Dunlop and Machiels as directors, ratify auditor and approve say-on-pay
--------------------------------------------------------------------------------

- A. Sinclair Dunlop re-elected with 67,011,560 for vs 19,188,626 against, 8,818,334 broker non-votes.
- Alec Machiels re-elected with 63,755,893 for vs 22,444,293 against, 8,818,334 broker non-votes.
- Ratification of Deloitte & Touche as auditor for FY2022: 75,696,485 for, 19,169,304 against.
- Advisory vote on executive compensation approved: 84,569,740 for, 1,617,364 against, 13,081 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1492422/000119312522166256/0001193125-22-166256-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1492422/000119312522166256/d317429d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-166256

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer